➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: January 22, 2021

DrugPatentWatch Database Preview

Patent: 8,414,895

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,414,895
Title:Tweak receptor
Abstract: The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.
Inventor(s): Kim; Kristine M. (Mill Creek, WA), Wiley; Steven R. (Seattle, WA), Ketchem; Randal R. (Snohomish, WA), Fanslow, III; William C. (Normandy Park, WA)
Assignee: Immunex Corporation (Thousand Oaks, CA)
Application Number:12/899,397
Patent Claims:see list of patent claims

Details for Patent 8,414,895

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Immunex Corporation (Thousand Oaks, CA) 2020-12-19 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,414,895

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 0145730   Start Trial
World Intellectual Property Organization (WIPO) 2006047172   Start Trial
United States of America 2002041876   Start Trial
United States of America 2002110853   Start Trial
United States of America 2004253610   Start Trial
United States of America 2005208046   Start Trial
United States of America 2006084143   Start Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.